
	Year ended December 31, 2025
	U.S. dialysis		Other - Ancillary services		Consolidated
Patient service revenues:
Medicare and Medicare Advantage	$	6,740,392	$		$	6,740,392
Medicaid and Managed Medicaid	871,695				871,695
Other government	349,651		914,387		1,264,038
Commercial	3,806,596		385,423		4,192,019
Other revenues:
Medicare and Medicare Advantage			507,613		507,613
Medicaid and Managed Medicaid			2		2
Commercial			15,399		15,399
Other(1)	24,610		99,462		124,072
Eliminations of intersegment revenues	(60,958)		(11,203)		(72,161)
Total	$	11,731,986	$	1,911,083	$	13,643,069


	Year ended December 31, 2024
	U.S. dialysis		Other - Ancillary services		Consolidated
Patient service revenues:
Medicare and Medicare Advantage	$	6,374,882	$		$	6,374,882
Medicaid and Managed Medicaid	863,947				863,947
Other government	343,705		717,735		1,061,440
Commercial	3,783,827		248,026		4,031,853
Other revenues:
Medicare and Medicare Advantage			463,731		463,731
Medicaid and Managed Medicaid			740		740
Commercial			21,396		21,396
Other(1)	24,356		58,862		83,218
Eliminations of intersegment revenues	(71,747)		(13,910)		(85,657)
Total	$	11,318,970	$	1,496,580	$	12,815,550


	Year ended December 31, 2023
	U.S. dialysis		Other - Ancillary services		Consolidated
Patient service revenues:
Medicare and Medicare Advantage	$	6,100,183	$		$	6,100,183
Medicaid and Managed Medicaid	833,744				833,744
Other government	354,304		500,137		854,441
Commercial	3,623,516		251,279		3,874,795
Other revenues:
Medicare and Medicare Advantage			460,991		460,991
Medicaid and Managed Medicaid			1,733		1,733
Commercial			32,329		32,329
Other(1)	25,251		52,754		78,005
Eliminations of intersegment revenues	(88,222)		(7,852)		(96,074)
Total	$	10,848,776	$	1,291,371	$	12,140,147

(1)Consists primarily of management service fees in the Company's U.S. dialysis business and research fees, management fees, and other non-patient service revenues in the Other - ancillary services businesses.